The effect of dosing frequency on the pharmacokinetics of a fentanyl HCl patient-controlled transdermal system (PCTS)

Clinical Pharmacokinetics

Volumn 44, Issue SUPPL. 1, 2005, Pages 17-24

  Sathyan, Gayatri ^a   Zomorodi, Katayoun ^a   Gidwani, Shalini ^a   Gupta, Suneel ^a  

^a ALZA CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; NALTREXONE; NARCOTIC ANALGESIC AGENT;

ADULT; AREA UNDER THE CURVE; ARM; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIZZINESS; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG ELIMINATION; DRUG HALF LIFE; DRUG POTENTIATION; DRUG SAFETY; DRUG TOLERABILITY; DRY SKIN; ERYTHEMA; FEMALE; HEADACHE; HUMAN; MALE; NAUSEA; NORMAL HUMAN; OPIOID INDUCED EMESIS; PAPULE; PATIENT CONTROLLED ANALGESIA; PRIORITY JOURNAL; PUSTULE; RANDOMIZED CONTROLLED TRIAL; APPLICATION SITE REACTION; CLINICAL ARTICLE; DRUG DISTRIBUTION; MACULOPAPULAR RASH; MAXIMUM CONCENTRATION; OPEN STUDY; PHARMACOKINETIC PARAMETERS; PLASMA CONCENTRATION-TIME CURVE; RANDOMIZED CONTROLLED TRIAL (TOPIC); TIME TO MAXIMUM PLASMA CONCENTRATION; VOMITING; DOUBLE BLIND PROCEDURE; INTRADERMAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; ADULT; ANALGESIA, PATIENT-CONTROLLED; ANALGESICS, OPIOID; AREA UNDER CURVE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; FENTANYL; HUMANS; MALE;

EID: 19644392170     PISSN: 03125963     EISSN: 03125963     Source Type: Journal    
DOI: 10.2165/00003088-200544001-00004     Document Type: Article

References (8)

1. Brown C, Moodie J, Bisley EJ, et al. Dose-ranging study of Transfenta for postoperative pain [abstract no. 888]. 17th Annual Scientific Meeting of the American Pain Society; 1998 Nov 5-8; San Diego, CA
2. Chelly JE, Grass F, Houseman TW, et al. The safety and efficacy of a fentanyl patient-controlled transdermal system for acute postoperative analgesia. Anesth Analg 2004; 98: 427-33
3. Viscusi ER, Reynolds L, Chung F, et al. Patient-controlled transdermal fentanyl hydrochloride vs. intravenous morphine pump for postoperative pain. JAMA 2004; 291: 1333-41
4. Gupta S, Bernstein K, Noorduin H, et al. Fentanyl delivery from an electrotransport system: delivery is a function of total current, not duration of current. J Clin Pharmacol 1998; 38: 951-8
5. Gupta S, Sathyan G, Phipps B, et al. Reproducible fentanyl doses delivered intermittently at different time intervals from an electron transport system. J Pharm Sci 1998; 88: 835-41
6. Sathyan G, Jaskowiak J, Evashenk M, Gupta S. Characterisation of the pharmacokinetics of the fentanyl HCl patient-controlled transdermal system (PCTS): effect of current magnitude and multiple-day dosing and comparison with IV fentanyl administration. Clin Pharmacokinet 2005; 44 Suppl. 1: 7-15
7. Gupta SK, Hwang S, Southam M, Sathyan G. Effects of application site and subject demographics on the pharmacokinetics of fentanyl HCl patient-controlled transdermal system (PCTS). Clin Pharmacokinet 2005; 44 Suppl. 1: 25-32
8. Data on file, ALZA Corporation, 2003